An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Teriflunomide (Aubagio) (14 mg Film-coated Tablet): Teriflunomide is Indicated as Monotherapy for the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis to Reduce the Frequency of Clinical Exacerbations and to Delay the Accumulation of Physical Disability [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Oct.
Top results in this bookTable of Contents
Ivacaftor (Kalydeco) 150 mg Tablet: For Treatment of Cystic Fibrosis with G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R, or G970R Mutation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.
Clinical Review Report: Lumacaftor/Ivacaftor (Orkambi): (Vertex Pharmaceuticals (Canada) Incorporated): Indication: For the treatment of cystic fibrosis in patients aged six years and older who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Mirabegron Extended-Release Tablets (Myrbetriq): Treatment of Overactive Bladder (OAB) with Symptoms of Urgency, Urgency Incontinence and Urinary Frequency [Internet].
Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
Geneva: World Health Organization; 2014 Dec.
NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3’-Azido-3’-deoxythymidine (AZT), Trimethoprim (TMP)/Sulfamethoxazole (SMX), and Folinic Acid Combinations Administered by Gavage to Swiss (CD-1®) Mice [Internet].
Rao GN, Cirvello JD, Rogers TR, et al.
Research Triangle Park (NC): National Institute of Environmental Health Sciences; 1998 Dec. (Toxicity Report, No. 2.)
Probe Reports from the NIH Molecular Libraries Program [Internet].
Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
Pharmacoeconomic Review Report: Lumacaftor/Ivacaftor (Orkambi): (Vertex Pharmaceuticals (Canada) Incorporated): Indication: For the treatment of cystic fibrosis in patients 6 years of age and older who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene [Internet].
Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants: Letter Report.
Institute of Medicine (US) Committee on the Perspectives on the Role of Intermittent Preventive Treatment for Malaria in Infants.
Washington (DC): National Academies Press (US); 2008.
1000 mg versus 600/650 mg Acetaminophen for Pain or Fever: A Review of the Clinical Efficacy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jun 17.
Some Aromatic Amines, Organic Dyes, and Related Exposures.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon (FR): International Agency for Research on Cancer; 2010. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 99.)
Intravenous Lidocaine for Chronic Pain: A Review of the Clinical Effectiveness and Guidelines [Internet].
Mayhew A, Argáez C.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jan 26.
Occupational Exposures of Hairdressers and Barbers and Personal Use of Hair Colourants; Some Hair Dyes, Cosmetic Colourants, Industrial Dyestuffs and Aromatic Amines.
Lyon (FR): International Agency for Research on Cancer; 1993. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 57.)
Intravenous Acetaminophen for the Management of Short-Term Post-Operative Pain: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet].
Harricharan S, Frey N.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct 12.
Some Aromatic Amines and related Compounds.
IARC Working Group on the Identification of Carcinogenic Hazards to Humans.
Lyon (FR): International Agency for Research on Cancer; 2021. (IARC Monographs on the Identification of Carcinogenic Hazards to Humans, No. 127.)
CADTH Canadian Drug Expert Committee Recommendation: Lumacaftor/Ivacaftor (Orkambi — Vertex Pharmaceuticals (Canada) Incorporated): Indication: Cystic fibrosis, F508del-cystic fibrosis transmembrane conductance regulator gene mutation in patients aged six years and older [Internet].
New Tools for the Schistosomiasis Elimination Toolbox: Barriers and Opportunities for the Development of a Topical Cercarial Anti-Penetrant [Internet].
Downs PW, Massoudi N, Dick A, et al.
Research Triangle Park (NC): RTI Press; 2017 Mar.
Chemical Agents and Related Occupations.
Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100F.)
Printing Processes and Printing Inks, Carbon Black and Some Nitro Compounds.
Lyon (FR): International Agency for Research on Cancer; 1996. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 65.)
Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42.
Lyon (FR): International Agency for Research on Cancer; 1987. (IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS, No. Supplement 7.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on